Dr. J. Rame, MD

Cardiovascular Disease Philadelphia, PA Male
NPI: 1417914953
Total Payments
$328,579
2024 Payments
$42,582
Companies
45
Transactions
617
Medicare Patients
1,240
Medicare Billing
$200,738

Payment Breakdown by Category

Other$210,039 (63.9%)
Travel$59,099 (18.0%)
Consulting$37,575 (11.4%)
Food & Beverage$21,231 (6.5%)
Education$635.54 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $166,659 45 50.7%
Travel and Lodging $59,099 122 18.0%
Honoraria $38,880 9 11.8%
Consulting Fee $37,575 19 11.4%
Food and Beverage $21,231 409 6.5%
Compensation for serving as faculty or as a speaker for a medical education program $4,500 6 1.4%
Education $635.54 7 0.2%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme LLC $142,466 109 $0 (2023)
E.R. Squibb & Sons, L.L.C. $42,727 57 $0 (2024)
Lexicon Pharmaceuticals, Inc. $42,491 32 $0 (2024)
Actelion Pharmaceuticals US, Inc. $41,321 63 $0 (2024)
Abbott Laboratories $23,866 142 $0 (2024)
Medtronic Vascular, Inc. $15,035 36 $0 (2020)
Fresenius USA Marketing, Inc. $10,750 16 $0 (2023)
Medtronic, Inc. $1,846 2 $0 (2022)
ABIOMED $1,702 24 $0 (2024)
Impulse Dynamics (USA) Inc. $815.95 10 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $42,582 100 Lexicon Pharmaceuticals, Inc. ($24,584)
2023 $93,777 142 Merck Sharp & Dohme LLC ($64,622)
2022 $109,199 153 Merck Sharp & Dohme LLC ($77,844)
2021 $4,176 50 Medtronic, Inc. ($1,800)
2020 $10,098 41 Abbott Laboratories ($8,274)
2019 $11,071 30 Fresenius USA Marketing, Inc. ($9,805)
2018 $9,199 33 Medtronic Vascular, Inc. ($8,791)
2017 $48,477 68 Actelion Pharmaceuticals US, Inc. ($40,287)

All Payment Transactions

617 individual payment records from CMS Open Payments — Page 1 of 25

Date Company Product Nature Form Amount Type
12/19/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $21.75 General
Category: Obesity
12/13/2024 AstraZeneca Pharmaceuticals LP — Food and Beverage In-kind items and services $25.00 General
12/12/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Travel and Lodging Cash or cash equivalent $791.86 General
Category: Cardiovascular
12/12/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Travel and Lodging Cash or cash equivalent $782.07 General
Category: Cardiovascular
12/12/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Travel and Lodging Cash or cash equivalent $236.90 General
Category: Cardiovascular
12/12/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $106.79 General
Category: Cardiovascular
12/12/2024 Abbott Laboratories THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) Food and Beverage In-kind items and services $13.95 General
Category: Heart Failure
11/18/2024 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $27.81 General
Category: Cardiology
11/14/2024 Baxter Healthcare FLOSEAL (Biological) Food and Beverage In-kind items and services $37.96 General
Category: Surgical Care
11/14/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $19.38 General
Category: CARDIOVASCULAR
11/08/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $4.76 General
Category: Cardiovascular
10/29/2024 Baxter Healthcare TISSEEL (Biological) Food and Beverage In-kind items and services $33.98 General
Category: Surgical Care
10/03/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $29.30 General
Category: Heart Failure and Hypertension
10/01/2024 United Therapeutics Corporation ORENITRAM (Drug), TYVASO Food and Beverage In-kind items and services $63.47 General
Category: Pulmonary Arterial Hypertension
09/27/2024 Abbott Laboratories THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) Food and Beverage In-kind items and services $122.56 General
Category: Heart Failure
09/25/2024 ABIOMED Impella (Device) Food and Beverage Cash or cash equivalent $91.33 General
Category: Cardiology/Vascular Diseases
09/19/2024 Baxter Healthcare FLOSEAL (Biological) Food and Beverage In-kind items and services $39.74 General
Category: Surgical Care
09/09/2024 Impulse Dynamics (USA) Inc. Optimizer (Device), Optimizer Food and Beverage Cash or cash equivalent $31.94 General
Category: Cardiovascular Device
09/03/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,125.00 General
Category: Cardiovascular
08/29/2024 AstraZeneca Pharmaceuticals LP — Food and Beverage In-kind items and services $60.55 General
08/28/2024 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Honoraria Cash or cash equivalent $3,120.00 General
Category: Inhibitor of SGLT2 and SGLT1
08/28/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $14.35 General
Category: Cardiology/Vascular Diseases
08/20/2024 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Food and Beverage In-kind items and services $120.48 General
Category: Inhibitor of SGLT2 and SGLT1
08/20/2024 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Travel and Lodging In-kind items and services $95.54 General
Category: Inhibitor of SGLT2 and SGLT1
08/15/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $115.78 General
Category: Cardiovascular
123…25»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 319 611 $138,385 $49,391
2022 8 395 744 $163,705 $64,959
2021 8 376 689 $133,470 $60,058
2020 6 150 331 $58,030 $26,330
Total Patients
1,240
Total Services
2,375
Medicare Billing
$200,738
Procedure Codes
42

All Medicare Procedures & Services

42 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 33 129 $24,510 $12,818 52.3%
99291 Critical care, first 30-74 minutes Facility 2023 16 68 $32,300 $10,532 32.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 45 70 $24,500 $8,341 34.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 34 58 $20,300 $7,227 35.6%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 20 20 $8,500 $3,034 35.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 15 15 $5,400 $2,178 40.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 17 21 $5,775 $1,631 28.2%
93750 Evaluation of lower heart chamber assist device Facility 2023 12 41 $4,920 $1,380 28.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 11 15 $1,950 $927.36 47.6%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 68 110 $6,050 $732.24 12.1%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 30 44 $3,080 $501.84 16.3%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Office 2023 18 20 $1,100 $87.49 8.0%
99291 Critical care, first 30-74 minutes Facility 2022 37 98 $46,550 $17,905 38.5%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 49 200 $38,000 $17,243 45.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 65 94 $29,290 $13,002 44.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 42 63 $19,105 $7,717 40.4%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 18 18 $6,480 $3,000 46.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 17 21 $5,055 $2,128 42.1%
93750 Evaluation of lower heart chamber assist device Facility 2022 13 43 $5,160 $1,471 28.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 11 13 $3,125 $1,085 34.7%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Office 2022 73 99 $5,445 $650.11 11.9%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2022 54 77 $4,235 $534.18 12.6%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 16 18 $1,260 $223.15 17.7%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 86 271 $51,490 $23,530 45.7%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 49 64 $16,320 $9,460 58.0%
12»

About Dr. J. Rame, MD

Dr. J. Rame, MD is a Cardiovascular Disease healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417914953.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. J. Rame, MD has received a total of $328,579 in payments from pharmaceutical and medical device companies, with $42,582 received in 2024. These payments were reported across 617 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($166,659).

As a Medicare-enrolled provider, Rame has provided services to 1,240 Medicare beneficiaries, totaling 2,375 services with total Medicare billing of $200,738. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Other Specialties Advanced Heart Failure and Transplant Cardiology, Cardiovascular Disease
  • Location Philadelphia, PA
  • Active Since 04/27/2006
  • Last Updated 01/19/2026
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • NPI Number 1417914953

Products in Payments

  • VERQUVO (Drug) $123,866
  • Inpefa (Drug) $42,491
  • HeartWare HVAD (Device) $16,835
  • UPTRAVI (Drug) $16,042
  • CAMZYOS (Drug) $15,617
  • THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $9,501
  • HeartMate 3 Left Ventricular Dev (Device) $6,992
  • CARDIOMEMS (Device) $2,319
  • HeartMate 3 Left Ventricular Assist Device (Device) $2,154
  • Impella (Device) $1,702
  • Circulatory Support (Device) $1,604
  • BVA-100 (Device) $531.10
  • OPTIMIZER SMART SYSTEM (Device) $500.00
  • Cardiovascular-Research only (Device) $425.00
  • JARDIANCE (Drug) $350.74
  • TYVASO (Drug) $346.41
  • remede System (Device) $343.12
  • HeartMate (Device) $301.55
  • AccuCinch (Device) $285.68
  • OPTIMIZER (Device) $242.76

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Philadelphia

Paul Forfia, Md, MD

Cardiovascular Disease — Payments: $1.4M

Cardiovascular Disease $1.4M

Quang Bui, Md, MD

Cardiovascular Disease — Payments: $1.0M

Cardiovascular Disease $1.0M

Anjali Vaidya, Md, MD

Cardiovascular Disease — Payments: $895,146

Cardiovascular Disease $895,146

Dean Karalis, Md, MD

Cardiovascular Disease — Payments: $760,521

Cardiovascular Disease $760,521

Ralph Verdino, Md, MD

Cardiovascular Disease — Payments: $683,076

Cardiovascular Disease $683,076

Francis Marchlinski, Md, MD

Cardiovascular Disease — Payments: $456,298

Cardiovascular Disease $456,298